News
People taking weight loss drugs typically start to lose weight within a few weeks. One study, funded by Mounjaro manufacturer ...
State Medicaid programs already are allowed to offer GLP-1 drugs for weight loss, but only 13 state programs currently do so. Meanwhile, Medicare currently covers GLP-1 drugs for people with a ...
Three Motley Fool contributors believe they've found such unstoppable stocks with the "it" factor to buy in August -- and ...
Eli Lilly drug Mounjaro resulted in a lower risk of heart attacks and strokes in patients with diabetes compared with the ...
Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.
The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...
The Trump administration is evaluating a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, ...
Stocktwits on MSN1d
Eli Lilly, Novo Nordisk Shares Rally As Trump Administration Reportedly Plans To Experiment Including Weight-loss Drugs Under Medicaid, Medicare
Shares of Eli Lilly And Co. (LLY) and Novo Nordisk (NVO) jumped on Friday following reports that the Trump administration is ...
Eli Lilly's growth is fueled by GLP-1 blockbusters and a solid pipeline, yet high valuations and reliance on key drugs ...
The Trump administration is contemplating a pilot program to cover weight-loss drugs under Medicare and Medicaid. The ...
All the health conditions weight-loss drugs are being used and tested for - Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some succe ...
1dOpinion
Novo Nordisk’s Weight Loss Lesson
Furious competition in GLP-1 drugs rebuts the anti-pharma crowd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback